Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2002;33:2750-2755
Published online before print November 21, 2002, doi: 10.1161/01.STR.0000044168.00485.02
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
33/12/2750    most recent
01.STR.0000044168.00485.02v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Meer, I. M.
Right arrow Articles by Witteman, J. C.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Meer, I. M.
Right arrow Articles by Witteman, J. C.M.
Related Collections
Right arrow Epidemiology
Right arrow Pathophysiology
Right arrow Risk Factors

(Stroke. 2002;33:2750.)
© 2002 American Heart Association, Inc.


Original Contributions

C-Reactive Protein Predicts Progression of Atherosclerosis Measured at Various Sites in the Arterial Tree

The Rotterdam Study

Irene M. van der Meer, MSc; Moniek P.M. de Maat, PhD; A. Elisabeth Hak, MD, PhD; Amanda J. Kiliaan, PhD; Antonio Iglesias del Sol, MD, PhD; Deirdre A.M. van der Kuip, MD, PhD; Rogier L.G. Nijhuis, MD; Albert Hofman, MD, PhD Jacqueline C.M. Witteman, PhD

From the Department of Epidemiology and Biostatistics, Erasmus Medical Center, Rotterdam (I.M. vd M., A.E.H., A.I. d S.; D.A.M. vd K., R.L.G.N., A.H., J.C.M.W.); Gaubius Laboratory, TNO-PG, Leiden (I.M. vd M., M.P.M. d M.); and Numico Research, Wageningen (A.J.K.), the Netherlands.

Correspondence to Dr J.C.M. Witteman, Erasmus Medical Center, Department of Epidemiology and Biostatistics, PO Box 1738, 3000 DR Rotterdam, Netherlands. E-mail witteman{at}epib.fgg.eur.nl

Background and Purpose— C-reactive protein (CRP) predicts myocardial infarction and stroke. Its role as a predictor of the progression of subclinical atherosclerosis is not yet known. We investigated whether CRP predicts progression of atherosclerosis measured at various sites in the arterial tree.

Methods— CRP levels were measured in a random sample of 773 subjects >=55 years of age who were participating in the Rotterdam Study. Subclinical atherosclerosis was assessed at various sites at 2 points in time, with a mean duration between measurements of 6.5 years.

Results— After adjustment for age, sex, and smoking habits, odds ratios (ORs) associated with CRP levels in the highest compared with the lowest quartile were increased for progression of carotid (OR, 1.9; 95% CI, 1.1 to 3.3), aortic (OR, 1.7; 95% CI, 1.0 to 3.0), iliac (OR, 2.0; 95% CI, 1.2 to 3.3), and lower extremity (OR, 1.9; 95% CI, 1.0 to 3.7) atherosclerosis. The OR for generalized progression of atherosclerosis as indicated by a composite progression score was 4.5 (95% CI, 2.3 to 8.5). Except for aortic atherosclerosis, these estimates hardly changed after additional adjustment for multiple cardiovascular risk factors. In addition, ORs for progression of atherosclerosis associated with high CRP levels were as high as those associated with the traditional cardiovascular risk factors high cholesterol, hypertension, and smoking. Geometric mean levels of CRP increased with the total number of sites showing progression of atherosclerosis (P=0.002 for trend).

Conclusions— CRP predicts progression of atherosclerosis measured at various sites in the arterial tree.


Key Words: atherosclerosis • C-reactive protein • inflammation • risk factors




This article has been cited by other articles:


Home page
StrokeHome page
J. F. Arenillas, J. Alvarez-Sabin, C. A. Molina, P. Chacon, I. Fernandez-Cadenas, M. Ribo, P. Delgado, M. Rubiera, A. Penalba, A. Rovira, et al.
Progression of Symptomatic Intracranial Large Artery Atherosclerosis Is Associated With a Proinflammatory State and Impaired Fibrinolysis
Stroke, May 1, 2008; 39(5): 1456 - 1463.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. Sander, C. Schulze Horn, C. Briesenick, and D. Sander
High-Sensitivity C-Reactive Protein Is Independently Associated With Early Carotid Artery Progression in Women But Not in Men: The INVADE Study
Stroke, November 1, 2007; 38(11): 2881 - 2886.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Sen, A. Hinderliter, P. K. Sen, J. Simmons, V. A. LeGrys, J. Beck, S. Offenbacher, K. Moss, and S. M. Oppenheimer
Association of Leukocyte Count With Progression of Aortic Atheroma in Stroke/Transient Ischemic Attack Patients
Stroke, November 1, 2007; 38(11): 2900 - 2905.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
S. S. Boekhoorn, J. R. Vingerling, J. C. M. Witteman, A. Hofman, and P. T. V. M. de Jong
C-reactive Protein Level and Risk of Aging Macula Disorder: The Rotterdam Study
Arch Ophthalmol, October 1, 2007; 125(10): 1396 - 1401.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. I. Parikh, S.-J. Hwang, M. G. Larson, L. A. Cupples, C. S. Fox, E. S. Manders, J. M. Murabito, J. M. Massaro, U. Hoffmann, and C. J. O'Donnell
Parental Occurrence of Premature Cardiovascular Disease Predicts Increased Coronary Artery and Abdominal Aortic Calcification in the Framingham Offspring and Third Generation Cohorts
Circulation, September 25, 2007; 116(13): 1473 - 1481.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. A. De Silva, F.-P. Woon, M.-P. Lee, C. P.L.H. Chen, H.-M. Chang, and M.-C. Wong
South Asian Patients With Ischemic Stroke: Intracranial Large Arteries Are the Predominant Site of Disease
Stroke, September 1, 2007; 38(9): 2592 - 2594.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. Schwartz, S. Osborne-Lawrence, L. Hahner, L. L. Gibson, A. K. Gormley, W. Vongpatanasin, W. Zhu, R. A. Word, D. Seetharam, S. Black, et al.
C-Reactive Protein Downregulates Endothelial NO Synthase and Attenuates Reendothelialization In Vivo in Mice
Circ. Res., May 25, 2007; 100(10): 1452 - 1459.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Cardellini, M. A. Marini, S. Frontoni, M. L. Hribal, F. Andreozzi, F. Perticone, M. Federici, D. Lauro, and G. Sesti
Carotid artery intima-media thickness is associated with insulin-mediated glucose disposal in nondiabetic normotensive offspring of type 2 diabetic patients
Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E347 - E352.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. Siemes, L. E. Visser, J.-W. W. Coebergh, T. A.W. Splinter, J. C.M. Witteman, A. G. Uitterlinden, A. Hofman, H. A.P. Pols, and B. H.Ch. Stricker
C-Reactive Protein Levels, Variation in the C-Reactive Protein Gene, and Cancer Risk: The Rotterdam Study
J. Clin. Oncol., November 20, 2006; 24(33): 5216 - 5222.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. R. Crouse III
Thematic review series: Patient-Oriented Research. Imaging atherosclerosis: state of the art
J. Lipid Res., August 1, 2006; 47(8): 1677 - 1699.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
W. Ambrosius, R. Kazmierski, S. Michalak, and W. Kozubski
Anti-inflammatory cytokines in subclinical carotid atherosclerosis
Neurology, June 27, 2006; 66(12): 1946 - 1948.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
V. Aboyans, M. H. Criqui, J. O. Denenberg, J. D. Knoke, P. M Ridker, and A. Fronek
Risk Factors for Progression of Peripheral Arterial Disease in Large and Small Vessels
Circulation, June 6, 2006; 113(22): 2623 - 2629.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. Sander, C. Schulze-Horn, H. Bickel, H. Gnahn, E. Bartels, and B. Conrad
Combined Effects of Hemoglobin A1c and C-Reactive Protein on the Progression of Subclinical Carotid Atherosclerosis: The INVADE Study
Stroke, February 1, 2006; 37(2): 351 - 357.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. P.S. Sie, F. A. Sayed-Tabatabaei, H.-H. S. Oei, A. G. Uitterlinden, H. A.P. Pols, A. Hofman, C. M. van Duijn, and J. C.M. Witteman
Interleukin 6 -174 G/C Promoter Polymorphism and Risk of Coronary Heart Disease: Results from the Rotterdam Study and a Meta-Analysis
Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 212 - 217.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Mineo, A. K. Gormley, I. S. Yuhanna, S. Osborne-Lawrence, L. L. Gibson, L. Hahner, R. V. Shohet, S. Black, J. E. Salmon, D. Samols, et al.
Fc{gamma}RIIB Mediates C-Reactive Protein Inhibition of Endothelial NO Synthase
Circ. Res., November 25, 2005; 97(11): 1124 - 1131.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
I. Tzoulaki, G. D. Murray, A. J. Lee, A. Rumley, G. D.O. Lowe, and F. G. R. Fowkes
C-Reactive Protein, Interleukin-6, and Soluble Adhesion Molecules as Predictors of Progressive Peripheral Atherosclerosis in the General Population: Edinburgh Artery Study
Circulation, August 16, 2005; 112(7): 976 - 983.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
O Y Bang, P H Lee, S R Yoon, M A Lee, I S Joo, and K Huh
Inflammatory markers, rather than conventional risk factors, are different between carotid and MCA atherosclerosis
J. Neurol. Neurosurg. Psychiatry, August 1, 2005; 76(8): 1128 - 1134.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Di Napoli, M. Schwaninger, R. Cappelli, E. Ceccarelli, G. Di Gianfilippo, C. Donati, H. C.A. Emsley, S. Forconi, S. J. Hopkins, L. Masotti, et al.
Evaluation of C-Reactive Protein Measurement for Assessing the Risk and Prognosis in Ischemic Stroke: A Statement for Health Care Professionals From the CRP Pooling Project Members
Stroke, June 1, 2005; 36(6): 1316 - 1329.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
E. M. Stuveling, S. J. L. Bakker, H. L. Hillege, P. E. de Jong, R. O. B. Gans, and D. de Zeeuw
Biochemical risk markers: a novel area for better prediction of renal risk?
Nephrol. Dial. Transplant., March 1, 2005; 20(3): 497 - 508.
[Full Text] [PDF]


Home page
HeartHome page
J G Ray, M M Mamdani, and W H Geerts
Giant cell arteritis and cardiovascular disease in older adults
Heart, March 1, 2005; 91(3): 324 - 328.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Diomedi, A. Pietroiusti, M. Silvestrini, B. Rizzato, L. M. Cupini, F. Ferrante, A. Magrini, A. Bergamaschi, A. Galante, and G. Bernardi
CagA-positive Helicobacter pylori strains may influence the natural history of atherosclerotic stroke
Neurology, September 14, 2004; 63(5): 800 - 804.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
S. Santos, T. W Rooke, K. R Bailey, J. P McConnell, and I. J Kullo
Relation of markers of inflammation (C-reactive protein, white blood cell count, and lipoprotein-associated phospholipase A2) to the ankle brachial index
Vascular Medicine, August 1, 2004; 9(3): 171 - 176.
[Abstract] [PDF]


Home page
StrokeHome page
C. M. L. Chapman, J. P. Beilby, B. M. McQuillan, P. L. Thompson, and J. Hung
Monocyte Count, But Not C-Reactive Protein or Interleukin-6, Is an Independent Risk Marker for Subclinical Carotid Atherosclerosis
Stroke, July 1, 2004; 35(7): 1619 - 1624.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. Hashimoto, K. Kitagawa, H. Hougaku, H. Etani, and M. Hori
Relationship Between C-Reactive Protein and Progression of Early Carotid Atherosclerosis in Hypertensive Subjects
Stroke, July 1, 2004; 35(7): 1625 - 1630.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Lombardo, L. M. Biasucci, G. A. Lanza, S. Coli, P. Silvestri, D. Cianflone, G. Liuzzo, F. Burzotta, F. Crea, and A. Maseri
Inflammation as a Possible Link Between Coronary and Carotid Plaque Instability
Circulation, June 29, 2004; 109(25): 3158 - 3163.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. B. J. Mancini, B. Dahlof, and J. Diez
Surrogate Markers for Cardiovascular Disease: Structural Markers
Circulation, June 29, 2004; 109(25_suppl_1): IV-22 - IV-30.
[Full Text] [PDF]


Home page
HypertensionHome page
E. M. Stuveling, S. J.L. Bakker, H. L. Hillege, J. G.M. Burgerhof, P. E. de Jong, R. O.B. Gans, D. de Zeeuw, and for the PREVEND Study Group
C-Reactive Protein Modifies the Relationship Between Blood Pressure and Microalbuminuria
Hypertension, April 1, 2004; 43(4): 791 - 796.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Paul, K. W.S. Ko, L. Li, V. Yechoor, M. A. McCrory, A. J. Szalai, and L. Chan
C-Reactive Protein Accelerates the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice
Circulation, February 10, 2004; 109(5): 647 - 655.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. F. Arenillas, J. Alvarez-Sabin, C. A. Molina, P. Chacon, J. Montaner, A. Rovira, B. Ibarra, and M. Quintana
C-Reactive Protein Predicts Further Ischemic Events in First-Ever Transient Ischemic Attack or Stroke Patients With Intracranial Large-Artery Occlusive Disease
Stroke, October 1, 2003; 34(10): 2463 - 2468.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. J. Lyon, R. E. Law, and W. A. Hsueh
Minireview: Adiposity, Inflammation, and Atherogenesis
Endocrinology, June 1, 2003; 144(6): 2195 - 2200.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
D. F. Denny Jr
Prediction of Restenosis after Carotid Artery Stent Implantation
Radiology, May 1, 2003; 227(2): 316 - 318.
[Full Text] [PDF]


Home page
BMJHome page
Minerva
BMJ, January 11, 2003; 326(7380): 112 - 112.
[Full Text] [PDF]